Blood Cancer Journal · 2018 · 92 citations · 49 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryHematologic Malignancy TherapyOncology PharmacologyAcute Myeloid Leukemia BiologyAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentCardiac GlycosidesGene Expression SignaturesRefractory Acute Myeloid Leukemia
Therapy for acute myeloid leukemia (AML) involves intense cytotoxic treatment and yet approximately 70% of AML are refractory to initial therapy or eventually relapse. This is at least partially driven by the chemo-resistant nature of the leukemic stem cells (LSCs) that sustain the disease, and therefore novel anti-LSC therapies could decrease relapses and improve survival. We performed in silico analysis of highly prognostic human AML LSC gene expression signatures using existing datasets of drug-gene interactions to identify compounds predicted to target LSC gene programs. Filtering against compounds that would inhibit a hematopoietic stem cell (HSC) gene signature resulted in a list of 151 anti-LSC candidates. Using a novel in vitro LSC assay, we screened 84 candidate compounds at multiple doses and confirmed 14 drugs that effectively eliminate human AML LSCs. Three drug families presenting with multiple hits, namely antihistamines (astemizole and terfenadine), cardiac glycosides (strophanthidin, digoxin and ouabain) and glucocorticoids (budesonide, halcinonide and mometasone), were validated for their activity against human primary AML samples. Our study demonstrates the efficacy of combining computational analysis of stem cell gene expression signatures with in vitro screening to identify novel compounds that target the therapy-resistant LSC at the root of relapse in AML.
49
Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks
Paul Shannon, Andrew Markiel, Owen Ozier et al. · Genome Research · 2003 · 54.3K citations · Full text
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Daniele Merico, Ruth Isserlin, Oliver Stueker et al. · PLoS ONE · 2010 · 2.4K citations · Full text
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text
Medicine, Hematology, Oncology +17
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin, Kristin J. Hope, Qiongli Zhai et al. · Nature Medicine · 2006 · 1.2K citations
Medicine, Hematology, Oncology +10